Yaz Required To Provide New Information On Warning Labels

The Food and Drug Administration (FDA) has recently issued documents recommending that birth control pills such as Yaz should contain additional warnings concerning the risk of blood clots. The FDA noted that patients and doctors should be informed about the risks. A statement from FDA scientists provides, “We believe that, because of the consistency in recent reports for an increased risk, product labeling should reflect that very real possibility.”

A predecessor to Yaz, Yasmin, was the first birth control pill using drospirenone, a new form of progestin. In 2006 Yasmin was reformulated and sold as Yaz. Although it was originally thought to have fewer side effects than older contraceptives, Yaz has now been shown to have a higher risk of blood clots than earlier types of birth control pills.

If you or a loved one has taken Yaz or other birth control pill containing drospirenone it is important to speak to an Albuquerque dangerous drug lawyer to determine your next steps. Birth control pills such as Yaz, Yasmin, or Ocella have been associated with several side effects in addition to blood clots including:

  • stroke
  •  heart attack
  • gallbladder disease

The FDA will also ask a panel of experts to provide advice on whether the drug is too dangerous for some women to take.

Yaz has also faced issues for deceptive marketing after its manufacturer – Bayer – claimed that it helped decrease acne and mood disorders.

If you or a loved one has suffered any injuries while taking Yaz, Yasmin, or Ocella, contact the Branch Law Firm for a free confidential consultation.